Jim Simons’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-172,067
| Closed | -$10.9M | – | 3332 |
|
|
2025
Q4 | $10.9M | Sell |
172,067
-117,900
| -41% | -$7.33M | 0.02% | 871 |
|
|
2025
Q3 | $15.9M | Buy |
289,967
+279,800
| +2,752% | +$11.5M | 0.02% | 845 |
|
|
2025
Q2 | $336K | Sell |
10,167
-110,500
| -92% | -$3.84M | ﹤0.01% | 3001 |
|
|
2025
Q1 | $4.85M | Sell |
120,667
-71,500
| -37% | -$3.29M | 0.01% | 1453 |
|
|
2024
Q4 | $9.04M | Sell |
192,167
-52,200
| -21% | -$2.71M | 0.01% | 1080 |
|
|
2024
Q3 | $12.9M | Sell |
244,367
-226,600
| -48% | -$12.6M | 0.02% | 916 |
|
|
2024
Q2 | $25.5M | Buy |
470,967
+105,000
| +29% | +$6.34M | 0.04% | 497 |
|
|
2024
Q1 | $25.7M | Buy |
365,967
+330,000
| +918% | +$25.5M | 0.04% | 526 |
|
|
2023
Q4 | $3M | Buy |
+35,967
| New | +$1.3M | ﹤0.01% | 1691 |
|
|
2023
Q1 | – | Sell |
-73,667
| Closed | -$3.38M | – | 4037 |
|
|
2022
Q4 | $3.38M | Buy |
+73,667
| New | +$3.17M | ﹤0.01% | 1742 |
|
|
2021
Q4 | – | Sell |
-338,367
| Closed | -$12.1M | – | 3952 |
|
|
2021
Q3 | $12.1M | Buy |
338,367
+267,600
| +378% | +$7.88M | 0.02% | 919 |
|
|
2021
Q2 | $1.4M | Buy |
+70,767
| New | +$1.66M | ﹤0.01% | 2488 |
|
|
2020
Q3 | – | Sell |
-71,067
| Closed | -$1.68M | – | 3426 |
|
|
2020
Q2 | $1.68M | Buy |
+71,067
| New | +$1.33M | ﹤0.01% | 2269 |
|
|
2020
Q1 | – | Sell |
-153,767
| Closed | -$1.63M | – | 3493 |
|
|
2019
Q4 | $1.63M | Buy |
153,767
+83,467
| +119% | +$857K | ﹤0.01% | 2416 |
|
|
2019
Q3 | $800K | Sell |
70,300
-298,000
| -81% | -$3.74M | ﹤0.01% | 2681 |
|
|
2019
Q2 | $4.14M | Buy |
368,300
+93,000
| +34% | +$897K | ﹤0.01% | 1914 |
|
|
2019
Q1 | $2.23M | Buy |
275,300
+256,100
| +1,334% | +$1.88M | ﹤0.01% | 2252 |
|
|
2018
Q4 | $121K | Buy |
+19,200
| New | +$141K | ﹤0.01% | 3206 |
|
|
2016
Q2 | – | Sell |
-184,479
| Closed | -$1.3M | – | 3359 |
|
|
2016
Q1 | $1.3M | Sell |
184,479
-334,799
| -64% | -$2.45M | ﹤0.01% | 2459 |
|
|
2015
Q4 | $5.43M | Buy |
519,278
+299,578
| +136% | +$2.94M | 0.01% | 1417 |
|
|
2015
Q3 | $1.47M | Buy |
219,700
+147,300
| +203% | +$1.01M | ﹤0.01% | 2175 |
|
|
2015
Q2 | $487K | Buy |
72,400
+2,933
| +4% | +$19.2K | ﹤0.01% | 2728 |
|
|
2015
Q1 | $471K | Buy |
+69,467
| New | +$519K | ﹤0.01% | 2617 |
|
|
2014
Q4 | – | Sell |
-498,161
| Closed | -$1.75M | – | 2991 |
|
|
2014
Q3 | $1.75M | Buy |
498,161
+240,624
| +93% | +$1.01M | ﹤0.01% | 1745 |
|
|
2014
Q2 | $1.23M | Buy |
257,537
+69,470
| +37% | +$424K | ﹤0.01% | 1968 |
|
|
2014
Q1 | $1.79M | Sell |
188,067
-147,200
| -44% | -$1.33M | ﹤0.01% | 1827 |
|
|
2013
Q4 | $2.18M | Buy |
+335,267
| New | +$2.2M | 0.01% | 1709 |
|
Other funds holding CYTK
VPM
VCM
ACA
Jim Simons's CYTK Position: Q1 2026 in Review
Jim Simons sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 172,067 shares — an estimated $10.9M sold.
Jim Simons first reported a position in CYTK in Q4 2013 and held it in 27 quarters. The position peaked at $25.7M in Q1 2024. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.
- Jim Simons reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
- Jim Simons sold 172,067 Cytokinetics shares in Q1 2026, an estimated $10.9M.
- Jim Simons first reported a position in Cytokinetics in Q4 2013 and held it in 27 quarters.
- Jim Simons's Cytokinetics position peaked at $25.7M in Q1 2024.
- 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.